153 related articles for article (PubMed ID: 17097921)
1. Parkinson's disease comorbid with narcolepsy presenting low CSF hypocretin/orexin level.
Maeda T; Nagata K; Kondo H; Kanbayashi T
Sleep Med; 2006 Dec; 7(8):662. PubMed ID: 17097921
[No Abstract] [Full Text] [Related]
2. Narcolepsy in Parkinson's disease.
Haq IZ; Naidu Y; Reddy P; Chaudhuri KR
Expert Rev Neurother; 2010 Jun; 10(6):879-84. PubMed ID: 20518604
[TBL] [Abstract][Full Text] [Related]
3. CSF orexin levels of Parkinson's disease, dementia with Lewy bodies, progressive supranuclear palsy and corticobasal degeneration.
Yasui K; Inoue Y; Kanbayashi T; Nomura T; Kusumi M; Nakashima K
J Neurol Sci; 2006 Dec; 250(1-2):120-3. PubMed ID: 17005202
[TBL] [Abstract][Full Text] [Related]
4. Progressive dopamine and hypocretin deficiencies in Parkinson's disease: is there an impact on sleep and wakefulness?
Wienecke M; Werth E; Poryazova R; Baumann-Vogel H; Bassetti CL; Weller M; Waldvogel D; Storch A; Baumann CR
J Sleep Res; 2012 Dec; 21(6):710-7. PubMed ID: 22747735
[TBL] [Abstract][Full Text] [Related]
5. Undetectable levels of CSF hypocretin-1 (orexin-A) in two prepubertal boys with narcolepsy.
Tsukamoto H; Ishikawa T; Fujii Y; Fukumizu M; Sugai K; Kanbayashi T
Neuropediatrics; 2002 Feb; 33(1):51-2. PubMed ID: 11930279
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid-orexin levels and sleep attacks in four patients with Parkinson's disease.
Asai H; Hirano M; Furiya Y; Udaka F; Morikawa M; Kanbayashi T; Shimizu T; Ueno S
Clin Neurol Neurosurg; 2009 May; 111(4):341-4. PubMed ID: 19097685
[TBL] [Abstract][Full Text] [Related]
7. Low cerebrospinal fluid hypocretin (orexin) and altered energy homeostasis in human narcolepsy.
Schuld A; Blum WF; Pollmächer T
Ann Neurol; 2002 May; 51(5):660; author reply 660-1. PubMed ID: 12112120
[No Abstract] [Full Text] [Related]
8. Low level of ventricular CSF orexin-A is not associated with objective sleepiness in PD.
Drouot X; Moutereau S; Lefaucheur JP; Palfi S; Covali-Noroc A; Margarit L; Stoïca-Herman M; Nguyen JP; Césaro P; d'Ortho MP
Sleep Med; 2011 Oct; 12(9):936-7. PubMed ID: 21978722
[No Abstract] [Full Text] [Related]
9. CSF orexin-A/hypocretin-1 concentrations in patients with intracerebral hemorrhage (ICH).
Dohi K; Ripley B; Fujiki N; Ohtaki H; Yamamoto T; Goto Y; Nakamachi T; Shioda S; Aruga T; Nishino S
Regul Pept; 2008 Jan; 145(1-3):60-4. PubMed ID: 17868933
[TBL] [Abstract][Full Text] [Related]
10. Normalization of hypocretin-1 in narcolepsy after intravenous immunoglobulin treatment.
Dauvilliers Y; Abril B; Mas E; Michel F; Tafti M
Neurology; 2009 Oct; 73(16):1333-4. PubMed ID: 19841387
[No Abstract] [Full Text] [Related]
11. [Narcolepsy--new implications of molecular biology].
Knudsen S; Jennum PJ
Ugeskr Laeger; 2006 Oct; 168(43):3699-704. PubMed ID: 17069732
[TBL] [Abstract][Full Text] [Related]
12. Reversal of symptomatic tumoral narcolepsy, with normalization of CSF hypocretin level.
Dauvilliers Y; Abril B; Charif M; Quittet P; Bauchet L; Carlander B; Touchon J
Neurology; 2007 Sep; 69(12):1300-1. PubMed ID: 17875919
[No Abstract] [Full Text] [Related]
13. Hypocretin (orexin) loss in Parkinson's disease.
Fronczek R; Overeem S; Lee SY; Hegeman IM; van Pelt J; van Duinen SG; Lammers GJ; Swaab DF
Brain; 2007 Jun; 130(Pt 6):1577-85. PubMed ID: 17470494
[TBL] [Abstract][Full Text] [Related]
14. Circadian rhythm of CSF monoamines and hypocretin-1 in restless legs syndrome and Parkinson's disease.
Poceta JS; Parsons L; Engelland S; Kripke DF
Sleep Med; 2009 Jan; 10(1):129-33. PubMed ID: 18207455
[TBL] [Abstract][Full Text] [Related]
15. Normal cerebrospinal fluid levels of hypocretin-1 (orexin A) in patients with fibromyalgia syndrome.
Taiwo OB; Russell IJ; Mignot E; Lin L; Michalek JE; Haynes W; Xiao Y; Zeitzer JM; Larson AA
Sleep Med; 2007 Apr; 8(3):260-5. PubMed ID: 17369087
[TBL] [Abstract][Full Text] [Related]
16. Hypocretin levels in sporadic and familial cases of canine narcolepsy.
Ripley B; Fujiki N; Okura M; Mignot E; Nishino S
Neurobiol Dis; 2001 Jun; 8(3):525-34. PubMed ID: 11442359
[TBL] [Abstract][Full Text] [Related]
17. CSF hypocretin-1 (orexin-A) levels in childhood narcolepsy and neurologic disorders.
Arii J; Kanbayashi T; Tanabe Y; Sawaishi Y; Kimura S; Watanabe A; Mishima K; Hishikawa Y; Shimizu T; Nishino S
Neurology; 2004 Dec; 63(12):2440-2. PubMed ID: 15623725
[No Abstract] [Full Text] [Related]
18. Parkinson's disease, sleepiness and hypocretin/orexin.
Baumann CR; Scammell TE; Bassetti CL
Brain; 2008 Mar; 131(Pt 3):e91. PubMed ID: 17898005
[No Abstract] [Full Text] [Related]
19. [Orexin (ORX)].
Sakurai T
Nihon Rinsho; 2010 Jul; 68 Suppl 7():633-6. PubMed ID: 20963897
[No Abstract] [Full Text] [Related]
20. On the value of measuring CSF hypocretin-1 in diagnosing narcolepsy.
Mignot E; Chen W; Black J
Sleep; 2003 Sep; 26(6):646-9. PubMed ID: 14572113
[No Abstract] [Full Text] [Related]
[Next] [New Search]
